Japer Therapeutics, Inc. Warrants (JSPRW)

• Market cap: $1.04M
• 1 day: -0.29%
• 5 days: -1.57%
• 1 month: -23.33%
• 3 months: -32.68%
• 6 months: -52.32%
• Year to date: -68.64%
• 1 year: -68.2%
• 5 years: -92.81%
• 10 years: -91.88%
• Sector: Healthcare
• Industry: Biotechnology

About: Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Employees: 64

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

197% more capital invested

Capital invested by funds: $129K [Q1] → $383K (+$254K) [Q2]

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

20% more funds holding

Funds holding: 5 [Q1] → 6 (+1) [Q2]

14.44% more ownership

Funds ownership: 6.07% [Q1] → 20.51% (+14.44%) [Q2]